NCT01439165 - Safety and Immunogenicity in Adults of Revaccination With Adacel® Vaccine 10 Years After a Previous Dose | Biotech Hunter

Enrollment

1,330

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

December 31, 2015

Study Completion Date

February 28, 2017

Conditions

TetanusDiphtheriaPertussisWhooping Cough

Interventions

BIOLOGICAL

Tetanus Toxoid, Diphtheria Toxoid and Pertussis Vaccine

0.5 mL, Intramuscular

BIOLOGICAL

Tetanus and Diphtheria Toxoids Adsorbed For Adult Use

0.5 mL, Intramuscular

Trial Locations (33)

11201

Brooklyn

14618

Rochester

14850

Ithaca

15025

Clairton

15224

Pittsburgh

15650

Latrobe

17033

Hershey

20850

Rockville

23456

Virginia Beach

27103

Winston-Salem

27612

Raleigh

30062

Marietta

30189

Woodstock

35802

Huntsville

40202

Louisville

44121

Cleveland

45229

Cincinnati

46545

Mishawaka

54449

Marshfield

54729

Chippewa Falls

61602

Peoria

63104

St Louis

65212

Columbia

72205

Little Rock

72401

Jonesboro

80304

Boulder

84075

Syracuse

87108

Albuquerque

92108

San Diego

98686

Vancouver

01801

Woburn

A0A2M0

Harbour Grace

A1B3V6

St. John's

All Listed Sponsors

lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY